MyFinsight
Home
Blog
About
Back
Income Statement
CERO THERAPEUTICS HOLDINGS, INC. (CEROW)
CERO THERAPEUTICS HOLDINGS, INC. (CEROW)
source: myfinsight.com
Net loss
attributable to common...
-$29,455,454
(2.20%↑ Y/Y)
Change in fair value of
preferred stock...
-$6,610,240
Interest income
$1,025
Deemed dividend on
series a, b, c, d and e...
$28,426,624
Net loss
-$1,028,830
(81.01%↑ Y/Y)
Total other income
(expenses), net
$2,817,636
(506.28%↑ Y/Y)
Derivative expense
$3,103,533
Interest expense
$690,044
(loss) gain on foreign
currency
-$52
Loss from operations
-$3,846,466
(18.57%↑ Y/Y)
Total operating
expenses
$3,846,466
(-18.57%↓ Y/Y)
General and
administrative
$2,110,453
(7.14%↑ Y/Y)
Research and development
$1,736,013
(-36.96%↓ Y/Y)
Back